---
layout: post
title: "基石药业-B：胃肠道间质瘤(「GIST」)同类首创精准靶向药AYVAKIT(avapritinib)在中国香港地区的新药上市申请已获批准"
date: 2021-12-28 09:10:38 +0800
categories: meigangdianxun
tags: 美港电讯新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02616" data-code="02616|116|5" data-code2="02616|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02616&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02616_0" data-code="K 02616|116|5" data-code2="K 02616|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>基石药业-B(02616.HK)：基石药业欣然宣布胃肠道间质瘤(「GIST」)同类首创精准靶向药AYVAKIT(avapritinib)在中国香港地区的新药上市申请已获批准。<br /></p><p class="em_media">（文章来源：美港电讯）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202112282227850875>

[返回美港电讯新闻](//finews.withounder.com/category/meigangdianxun.html)｜[返回首页](//finews.withounder.com/)